awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37902619-FDEB5FF4-F9A2-401B-8821-6B50E893BDAE
Q37902619-FDEB5FF4-F9A2-401B-8821-6B50E893BDAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37902619-FDEB5FF4-F9A2-401B-8821-6B50E893BDAE
Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices.
P2860
Q37902619-FDEB5FF4-F9A2-401B-8821-6B50E893BDAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37902619-FDEB5FF4-F9A2-401B-8821-6B50E893BDAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fee65fad9ae07d56e0186a4cb5c5574df485e051
P2860
Immunotoxicity profile of natalizumab.